Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Annual Review of Immunology is Scopus-indexed (Q1, CiteScore 56.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Annual Reviews Inc..
Checked against the index lists dated .
ISSN 0732-0582Verify ISSN ↗1545-3278Verify ISSN ↗
Publisher: Annual Reviews Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology | 2 / 243 | 99th | Q1 |
| Immunology and Allergy | 2 / 234 | 99th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1983–present, best quartile Q1, CiteScore 56.5.
Annual Review of Immunology is Q1 in Immunology (rank 2 of 243) and Q1 in Immunology and Allergy (rank 2 of 234), by CiteScore 2025.
Annual Review of Immunology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 56.5, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 16.066, quartile Q1, with an H-index of 349.
Annual Review of Immunology is published by Annual Reviews Inc. Its print ISSN is 0732-0582 and its online ISSN is 1545-3278.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Annual Review of Immunology has an h-index of 442 and a 2-year mean of 32.01 citations per paper (OpenAlex). Its Scopus CiteScore is 56.5, quartile Q1. On 2-year citations it ranks #1 of 240 Scopus journals in Immunology.
Annual Review of Immunology published 29 papers in 2025; its busiest recent year was 2018 with 34. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2022–2026), authors are most often from United States (51.3%), United Kingdom (8.5%) and France (6.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.